Molecular Diagnostics Market Size, Share, Growth, Trends and Outlook, 2023

Molecular Diagnostics Market – Global Industry Analysis Report,
Share, Size, Growth, Price Trends and Forecast, 2022:
Fractovia.org
A new study based report by Global Market Insights Inc. projects the Molecular
diagnostics market to be valued at USD $5.4 billion in the year 2015 and is likely to
witness growth at over CAGR 8.1% which is approximately USD$10 billion by the year
2023.Molecular diagnosis helps in timely detection of severe infectious diseases,
genetic diseases and detection of cancer at an early stage. Expenditure on healthcare
products and its awareness has been the reason for growing demand in the industry.
As per the WHO (World Health Organization), an increase in elderly population who
are suffering with common occurrences of infectious ailments is anticipated to grow by
8% by the year 2050. Furthermore, as per the reports by CDC (Centers for Disease
Control and Prevention, every year roughly 19 million people are infected by STD
(sexually transmitted diseases) ranging in the age group of 15 to 25 years of age. In
the year 2015, the Molecular diagnostics market was conquered by STD (sexually
transmitted diseases) by generating revenue up to USD $1 billion, followed by HIV.
The HPV market is expected to grow over 9.8% CAGR in the coming years. Hence
the market is witnessing upsurge in the number of clinical studies and research
conducted every year, which has eventually accelerated the creation and demand for
new medicines.
The United States is projected to be the largest market in the segment of the market
which is also foreseeing a grown of USD $402 billion by the year 2023. Attributing
factors are high awareness levels amongst the patients, high research & development
resulting in drug discovery and healthcare infrastructure. The molecular diagnostics
market in Asia Pacific region is expected to grow by 16% of global revenue by 2023,
followed by China & India displaying strong infrastructure and promotion of preventive
healthcare treatments. Malaysia is probably coming up as a rewarding market in the
coming years in the field of modern molecular diagnostic tools, planned for a CAGR
growth over 11% in the coming years.
Molecular diagnostics market share of 40% was acquired by Abbott Laboratories,
Danaher Corporation and Roche Diagnostics in the year 2015. Other active players in
the market are Bayer Healthcare, Novartis, and Siemens Healthcare amongst others.
Sedentary lifestyle, decreased immunity levels and lack of awareness gives rise to the
patient base resulting in the growth in the market. Methods of prevention of epidemics
and its medicines is the platform for the economic growth of this market.
1 | P a g e

To access sample pages or view this report titled, “Molecular Diagnostics Market
Size By Infectious Disease (Flu, Tuberculosis, Meningitis, RSV Virus, Hepatitis
B, Hepatitis C, HPV, STD, HIV, Dengue, Gonorrhea, Chlamydia, TORCH, H.
Pylori), By Technology (PCR, Real-Time PCR, DNA/RNA Purification), Industry
Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain,
Portugal, Italy, Russia, Denmark, Norway, Sweden, Israel, Japan, China, India,
Sri Lanka, Pakistan, Philippines, South Korea, Australia, New Zealand, Vietnam,
Thailand, Mexico, Brazil, Argentina, Colombia, Chile, Peru, South Africa, Nigeria,
Morocco, Egypt, KSA, UAE, Jordan, Qatar), Application Potential, Price Trend,
Competitive Market Share & Forecast, 2016 - 2023” in detail along with the table of
contents, please click on the link below:
https://www.fractovia.org/news/industry-research-report/molecular-diagnosticsmarket
2 | P a g e

Segmentation of Molecular Diagnostics Market:
Global Market Insights has segmented the molecular diagnostics industry on the basis of
product, type and region:
Global Molecular Diagnostics Analysis, By Infectious Disease (Revenue,
USD Million, 2012 - 2023)
o Flu
o RSV virus
o Tuberculosis
o Meningitis
o Chlamydia
o Gonorrhea
o HIV market
o Hepatitis C
o Hepatitis B
o HPV
o STD
o Dengue
o H. pylori
o TORCH
o Others
Global Molecular Diagnostics Technology Analysis (Revenue, USD
Million, 2012 - 2023)
o PCR
Real Time PCR
DNA/RNA Purification
o Others
Global Molecular Diagnostics Regional Analysis (Revenue, USD Million,
2012 - 2023)
o North America
U.S.
Canada
o Europe
Germany
UK
France
Spain
Portugal
Italy
Russia
3 | P a g e

o
o
o
o
Denmark
Norway
Sweden
Israel
Asia Pacific
China
India
Japan
Sri Lanka
Pakistan
Philippines
South Korea
Australia
New Zealand
Vietnam
Thailand
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Africa
South Africa
Nigeria
Morocco
Egypt
Middle East
Saudi Arabia
UAE
Jordan
Qatar
4 | P a g e

About Fractovia.org
Fractovia.org is one of India's leading in-house and free news portal. It is fully
automated, and operates on a constant premise, interfacing with news sites and
offering redesigned breaking features to readers across the globe. Our mission is to
offer individuals opportunities for connections with news writers and distributors which
they can pursue. We operate by mapping articles pertaining to breaking news,
constantly and progressively, against a pre-determined word-based theme, offering
important connections to readers and clients, as well as distributers.
Contact Us:
Fractovia
29L Atlantic Avenue,
Suite L 105, Ocean View,
Delaware 19970
United States
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@fractovia.org
Website: https://www.fractovia.org
5 | P a g e